SCHEMBL1162275

SCHEMBL1162275

C=CCCc1ccccc1OCC(C)(C)[SiH](C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.35
ALDH1A1 P00352 4/20 0.35
HTR1A P08908 2/20 0.33
DRD2 P14416 1/20 0.33
ADRB2 P07550 3/20 0.33
ADRB1 P08588 3/20 0.33
LMNA P02545 2/20 0.33
ADRB3 P13945 1/20 0.33
ADRA2C P18825 1/20 0.33
SLC6A2 P23975 1/20 0.33
BDKRB2 P30411 1/20 0.33
SLC6A4 P31645 1/20 0.33
ADRA1A P35348 1/20 0.33
HTR2B P41595 1/20 0.33
KCNH2 Q12809 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33
ABCB1 P08183 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2881707 0.77 RIPK1 (0.36) ALDH1A1HTR1ADRD2SLC6A2SLC6A4
SCHEMBL8073005 0.77 L3MBTL1 (0.51) ALDH1A1HTR1ADRD2TDP1THRA
SCHEMBL22700920 0.75 KDM4E (0.53) ALDH1A1HTR1ADRD2TSHRKDM4E
SCHEMBL8070949 0.74 MAPT (0.45) ALDH1A1SLC6A2SLC6A4KCNH2KDM4E
SCHEMBL9854692 0.74 ABCB1 (0.40) BCHEALDH1A1HTR1ADRD2ADRB2
SCHEMBL8062343 0.73 TAAR1 (0.58) ALDH1A1KCNH2ABCB1
SCHEMBL30136331 0.73 TAAR1 (0.58) ALDH1A1KCNH2ABCB1
SCHEMBL8072069 0.73 CYP1A2 (0.49) ALDH1A1CYP1A2TSHRKDM4ETHRA
SCHEMBL28575949 0.72 HRH1 (0.44) BCHEHTR1ADRD2SLC6A2SLC6A4
SCHEMBL9194683 0.70 HTR7 (0.46) ALDH1A1HTR1ALMNAADRA2CCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2499148-B1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2017-01-18 EP disclosed
US-9512139-B2 Conformationally constrained, fully synthetic macrocyclic compounds POLYPHOR AG (CH) 2016-12-06 US disclosed
US-20120270881-A1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2012-10-25 US disclosed
EP-2499148-A2 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS Polyphor Ag (CH) 2012-09-19 EP disclosed
WO-2011014973-A2 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2011-02-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120270881-A1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS KCNB1, KCNAB1, KCNMB1 BCHE 3865/4885ALDH1A1 4142/4885HTR1A 46/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.